rs2229263

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004525.3(LRP2):​c.248A>G​(p.Asn83Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 1,613,762 control chromosomes in the GnomAD database, including 71,748 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8514 hom., cov: 32)
Exomes 𝑓: 0.29 ( 63234 hom. )

Consequence

LRP2
NM_004525.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.752

Publications

35 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.2864037E-4).
BP6
Variant 2-169318824-T-C is Benign according to our data. Variant chr2-169318824-T-C is described in ClinVar as Benign. ClinVar VariationId is 129511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.443 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.248A>G p.Asn83Ser missense_variant Exon 3 of 79 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.248A>G p.Asn83Ser missense_variant Exon 3 of 78 XP_011509485.1
LRP2XM_047444340.1 linkc.-677A>G 5_prime_UTR_variant Exon 3 of 79 XP_047300296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.248A>G p.Asn83Ser missense_variant Exon 3 of 79 NM_004525.3 ENSP00000496870.1 P98164
LRP2ENST00000443831.1 linkc.248A>G p.Asn83Ser missense_variant Exon 3 of 23 2 ENSP00000409813.1 E9PC35

Frequencies

GnomAD3 genomes
AF:
0.326
AC:
49520
AN:
151936
Hom.:
8498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.448
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.204
Gnomad FIN
AF:
0.263
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.295
Gnomad OTH
AF:
0.320
GnomAD2 exomes
AF:
0.272
AC:
68407
AN:
251368
AF XY:
0.270
show subpopulations
Gnomad AFR exome
AF:
0.448
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.333
Gnomad EAS exome
AF:
0.280
Gnomad FIN exome
AF:
0.260
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.272
GnomAD4 exome
AF:
0.290
AC:
423737
AN:
1461708
Hom.:
63234
Cov.:
40
AF XY:
0.287
AC XY:
208996
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.452
AC:
15124
AN:
33474
American (AMR)
AF:
0.171
AC:
7625
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
8734
AN:
26134
East Asian (EAS)
AF:
0.289
AC:
11455
AN:
39696
South Asian (SAS)
AF:
0.198
AC:
17112
AN:
86256
European-Finnish (FIN)
AF:
0.260
AC:
13865
AN:
53416
Middle Eastern (MID)
AF:
0.278
AC:
1604
AN:
5766
European-Non Finnish (NFE)
AF:
0.297
AC:
330503
AN:
1111878
Other (OTH)
AF:
0.293
AC:
17715
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
17557
35114
52671
70228
87785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10888
21776
32664
43552
54440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.326
AC:
49573
AN:
152054
Hom.:
8514
Cov.:
32
AF XY:
0.325
AC XY:
24126
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.448
AC:
18581
AN:
41462
American (AMR)
AF:
0.236
AC:
3605
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.331
AC:
1148
AN:
3470
East Asian (EAS)
AF:
0.276
AC:
1431
AN:
5176
South Asian (SAS)
AF:
0.204
AC:
984
AN:
4824
European-Finnish (FIN)
AF:
0.263
AC:
2781
AN:
10578
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.295
AC:
20073
AN:
67964
Other (OTH)
AF:
0.317
AC:
669
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1713
3426
5138
6851
8564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.309
Hom.:
28534
Bravo
AF:
0.329
TwinsUK
AF:
0.286
AC:
1059
ALSPAC
AF:
0.294
AC:
1133
ESP6500AA
AF:
0.435
AC:
1915
ESP6500EA
AF:
0.293
AC:
2524
ExAC
AF:
0.278
AC:
33762
Asia WGS
AF:
0.228
AC:
796
AN:
3478
EpiCase
AF:
0.304
EpiControl
AF:
0.310

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Donnai-Barrow syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
0.072
DANN
Benign
0.29
DEOGEN2
Benign
0.15
T;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.50
.;T;T
MetaRNN
Benign
0.00093
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.080
N;N;.
PhyloP100
-0.75
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.060
.;N;N
REVEL
Benign
0.13
Sift
Benign
0.82
.;T;T
Sift4G
Benign
0.74
.;T;T
Polyphen
0.0030
B;B;B
Vest4
0.083, 0.038
MPC
0.19
ClinPred
0.0000096
T
GERP RS
-6.3
Varity_R
0.042
gMVP
0.23
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229263; hg19: chr2-170175334; COSMIC: COSV55541386; API